Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Olfactory impairment associated with reduced physical capacity 24 months after COVID-19
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.ORCID iD: 0009-0001-5257-8109
Umeå University, Faculty of Medicine, Department of Diagnostics and Intervention.ORCID iD: 0000-0003-0309-1852
Umeå University, Faculty of Science and Technology, Department of Physics.ORCID iD: 0000-0002-9313-3499
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.ORCID iD: 0000-0003-2018-8592
Show others and affiliations
2025 (English)In: Brain, Behavior, and Immunity - Health, E-ISSN 2666-3546, Vol. 47, article id 101032Article in journal (Refereed) Published
Abstract [en]

Background: Olfactory impairment has been associated with adverse health outcomes, particularly in older populations, including cognitive decline, malnutrition, and frailty. The COVID-19 pandemic highlighted olfactory impairment as a key symptom affecting individuals across all age groups, raising concerns about its long-term impacts. This study investigates the association between post-acute olfactory impairment and long-term physical capacity in COVID-19 patients, hypothesizing that impaired olfaction is linked to reduced physical performance.

Methods: This prospective cohort study included 63 hospitalized and non-hospitalized COVID-19 patients (38.1 % women; median age 51 years, IQR 47.0–60.0) who underwent olfactory testing 1–3 months post-infection. Olfactory assessments included threshold screening, supra-threshold intensity ratings, and an odour identification test. Physical capacity was assessed using the 1-min sit-to-stand test at follow-ups (3, 6, 12, and 24 months). Partial correlation analysis and linear mixed models were used to analyse the data, adjusting for covariates such as age, sex, BMI, comorbidities, smoking status, and severity of infection.

Results: In the early post-acute phase, 36.5 % of participants exhibited olfactory impairment. We identified a significant, negative correlation between objectively tested olfactory impairment and physical capacity at all follow-ups. In a linear mixed model adjusted for relevant covariates, olfactory impairment was associated with reduced physical capacity up to 24 months after infection. The association strengthened over time, reflected by the increasing beta values for the interaction term: 0.09 (p = 0.200) at 6 months, 0.13 (p = 0.053) at 12 months, and 0.23 (p = 0.001) at 24 months.

Conclusion: Individuals with olfactory impairment in the early post-acute phase of COVID-19 infection were more likely to exhibit diminished physical capacity 24 months later. This study highlights the broader implications of olfactory impairment, previously noted mainly in older populations, demonstrating its relevance across age groups. The COVID-19 pandemic presented a unique opportunity to investigate this relationship, enhancing our understanding of how olfactory impairments relate to long-term physical performance. These findings emphasize the need for further research with larger, more diverse cohorts and objective longitudinal assessments to confirm and extend these observations.

Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 47, article id 101032
National Category
Epidemiology Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:umu:diva-242018DOI: 10.1016/j.bbih.2025.101032ISI: 001516194100001PubMedID: 40606937Scopus ID: 2-s2.0-105008225858OAI: oai:DiVA.org:umu-242018DiVA, id: diva2:1982441
Funder
Region Västerbotten, RV-992412Region Västerbotten, RV-993597Swedish Heart Lung Foundation, 20200325Swedish Heart Lung Foundation, 20210078Knut and Alice Wallenberg Foundation, VC-2020-0015Swedish Research Council, 2016-06514Science for Life Laboratory, SciLifeLabAvailable from: 2025-07-08 Created: 2025-07-08 Last updated: 2025-07-08Bibliographically approved

Open Access in DiVA

fulltext(467 kB)76 downloads
File information
File name FULLTEXT01.pdfFile size 467 kBChecksum SHA-512
7e92b32e754564f419a691cd04fe2db342e6f4a56d83bf38509cd247693833e64730b07e81c3b1972130672f77aa3d263a24aeea9251b46419d840701d05ff63
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Granvik, ChristofferLind, AliciaBarros, Guilherme W.F.Ahlm, ClasAndersson, SaraAndersson, LinusNormark, Johan

Search in DiVA

By author/editor
Granvik, ChristofferLind, AliciaBarros, Guilherme W.F.Ahlm, ClasAndersson, SaraAndersson, LinusNormark, Johan
By organisation
Department of Clinical MicrobiologyDepartment of Diagnostics and InterventionDepartment of PhysicsDepartment of Epidemiology and Global HealthDepartment of Psychology
In the same journal
Brain, Behavior, and Immunity - Health
EpidemiologyPublic Health, Global Health and Social Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 76 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 407 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf